Background A key component of many asthma management guidelines is the recommendation
for patient education and regular medical review. A number of controlled trials have …

Background Asthma is a respiratory (airway) condition that affects an estimated 300 million
people worldwide and is associated with significant morbidity and mortality. Omalizumab is a …

Given that the apnea–ventilation cycle length during central sleep apnea (CSA) with congestive
heart failure (CHF) is ∼ 70 s, we hypothesized that rapidly responsive peripheral CO 2 …

Background There is great interest in chronic obstructive pulmonary disease (COPD) and
the associated large burden of disease. COPD is characterised by frequent day by day …

Background Acute exacerbations of chronic obstructive pulmonary disease (COPD) are a
major cause of hospital admission and mortality. They contribute to long‐term decline in lung …

There is controversy about the role of β -agonists in asthma mortality, and the impact of
asthma management plans remains unclear. We compared blood β -agonist levels in patients …

Background: The use of reverse transcription-polymerase chain reaction (RT-PCR) to measure
mRNA levels has led to the common use of β-actin and GAPDH housekeeping genes as …

Background—Recent studies suggest that acute pulmonary congestion induces hyperventilation
and that hyperventilation-related hypocapnia leads to ventilatory control instability and …

Background A key component of many asthma management guidelines is the recommendation
for patient education and regular medical review. A number of controlled trials have …

Background Omalizumab is a recombinant humanised monoclonal antibody directed against
immunoglobulin E (anti‐IgE) to inhibit the immune system's response to allergen exposure. …